Begin main content

Communication Updates

In keeping with the pCODR principle of transparency, CADTH regularly publishes pCODR Communication Updates of interest to stakeholders. CADTH also posts pCODR Drug Review Updates.

You can subscribe to E-Alerts to be notified when new items are added to either page.

  • June 13, 2017
    pCODR Update 61
    Introducing New Patient Input Template and Integrating Companion Diagnostic Assessment Into CADTH’s Drug Review Programs
  • March 16, 2017
    pCODR Update 60
    Expanding CADTH’s Drug Review Processes to include Radiopharmaceutical Submissions and Other Process Alignment Implementations
  • November 21, 2016
    pCODR Update 59
    Consultation on CADTH’s Proposed Process for the Assessment of Companion Diagnostics
  • September 27, 2016
    pCODR Update 58
    Workshop for Patient Groups: Role of Health Technology Assessment in Cancer Drug Funding Decisions
  • September 12, 2016
    pCODR Update 57
    Feedback on Proposed Revisions to Patient Input Template for CDR and pCODR
  • July 26, 2016
    pCODR Update 56
    Joint Collaboration to Introduce Health Technology Assessment Patient Engagement Navigator Initiative
  • May 11, 2016
    pCODR Update 55
    Recruitment: Health Technology Assessment Patient Engagement Navigator
  • May 2, 2016
    pCODR Update 54
    Recruitment: pCODR Expert Review Committee Member
  • March 24, 2016
    pCODR Update 53
    (Introducing a Common CADTH Recommendation Framework and Establishing a Minimum Period of 120 Calendar Days for Advance Notification of Anticipated Submissions and Resubmissions for CADTH CDR and pCODR)
  • February 25, 2016
    pCODR Update 52
    (Update on Procedures for the CADTH Common Drug Review and pan-Canadian Oncology Drug Review: Mandatory Disclosure of a Submitted Drug Price)
  • February 1, 2016
    pCODR Update 51
    (New Pilot Initiative: Increasing Opportunities for Clinician Input and Feedback in CADTH pan-Canadian Oncology Drug Review Process)
  • October 26, 2015
    Update: pCODR Update 45
    (Consultation to Increase Opportunity for Clinician Input and Feedback in CADTH
    pan-Canadian Oncology Drug Review Process – Deadline Extended)
  • October 9, 2015
    pCODR Update 50
    (Consultation on Recommendation Framework for CADTH Common Drug Review and pan-Canadian Oncology Drug Review Programs)
  • October 9, 2015
    pCODR Update 49
    (New Permanent Homepage for CADTH’s pCODR Program)
  • October 6, 2015
    pCODR Update 48
    (Expanding the CADTH Drug Review Process to Receive Patient Input Submissions From Individual Patients and Caregivers)
  • September 30, 2015
    pCODR Update 47
    (Consultation on Procedures for the CADTH Common Drug Review and pan-Canadian Oncology Drug Review)
  • September 28, 2015
    pCODR Update 46
    (Introducing Cancer Drug Pipeline Information for Patient Advocacy Groups)
  • September 24, 2015
    pCODR Update 45
    (Consultation to Increase Opportunity for Clinician Input and Feedback in CADTH pan-Canadian Oncology Drug Review Process)
  • August 27, 2015
    pCODR Update 44
    (New Resources to Help Strengthen pCODR Patient Advocacy Group Submissions)
  • June 22, 2015
    pCODR Update 43
    (Recruitment:: Patient Member)
  • June 15, 2015
    Update: pCODR Update 41
    (Recruitment: pCODR Expert Review Committee Members - Deadline Extended)
  • May 28, 2015
    pCODR Update 42
    (Recruitment: pCODR Expert Review Committee Chair)
  • April 1, 2015
    pCODR Update 40
    (Notice on Implementation of Guidelines for Manufacturers on Application Fees for pCODR)
  • March 26, 2015
    pCODR Update 39
    (Stakeholder Engagement Sessions Summary Report on Phase II of pCODR Transfer to CADTH – Feedback Requested)
  • March 23, 2015
    pCODR Update 38
    (pCODR's New Toronto Office Location)
  • March 5, 2015
    pCODR Update 37
    (Consultation on Draft Guidelines for Manufacturers on Application Fees for pCODR)
  • December 22, 2014
    pCODR Update 36
    (Invitation to Stakeholder Engagement Session on Phase II of the Transfer of pCODR to CADTH – Pharmaceutical Industry and Consultants)
  • December 22, 2014
    pCODR Update 35
    (Invitation to Stakeholder Engagement Session on Phase II of the Transfer of pCODR to CADTH – Patient Groups and Oncology Professionals)
  • October 20, 2014
    pCODR Update 34
    (Recruitment: Health Economist for the pCODR Expert Review Committee)
  • September 04, 2014
    pCODR Update 33
    (CCAN & pCODR Announce the Establishment of Patient HTA Navigator)
  • July 23, 2014
    pCODR Update 32
    (pCODR Transition Stakeholder Consultation Summary Report)
  • May 16, 2014
    pCODR Update 31
    (Update on pCODR Procedures and Guidelines Consultation)
  • April 25, 2014
    pCODR Update 30
    (Invitation to Stakeholder Information Session on the Transfer of pCODR to CADTH
    – Pharmaceutical Industry)
  • April 25, 2014
    pCODR Update 29
    (Invitation to Stakeholder Information Session on the Transfer of pCODR to CADTH
    – Patient Groups and Oncology Professionals)
  • April 17, 2014
    pCODR Update 28
    (Stakeholder Notification: Changes to pCODR Procedural Review Guidelines)
  • April 8, 2014
    pCODR Update 27
    (Invitation to Free Workshop Session: Demystifying the pCODR Patient Submission Process)
  • April 1, 2014
    pCODR Update 26
    (Stakeholder Notification: Information on pCODR Transition to CADTH)
  • February 11, 2014
    pCODR Update 25
    (Consultation on pCODR Procedures and Guidelines Changes)
  • November 1, 2013
    pCODR Update 24
    (Tutorial on how cancer drug funding decisions are made)
  • October 09, 2013
    pCODR Update 23
    (Introducing the pCODR Patient Guide: Invitation to Workshop Session – Patient Advocacy Groups)
  • September 10, 2013
    pCODR Update 22
    (Update - Recruitment: Hematologist for the pCODR Expert Review Committee)
  • May 30, 2013
    pCODR Update 21
    (pCODR Update - Public Posting of Provincial Funding Decisions)
  • April 16, 2013
    pCODR Update 20
    (pCODR Update - All Stakeholders)
  • April 2, 2013
    pCODR Update 19
    (Invitation to Informational Webinar – Patient Advocacy Groups)
  • March 4, 2013
    pCODR Update 18
    (Update: A Step-by-Step Guide on How Patients Can Provide Input on Drug Technology Assessments)
  • September 11, 2012
    pCODR Update 17
    (Invitation for Proposals)
  • June 4, 2012
    pCODR Update 16
    (pCODR Update - Patient Advocacy Groups)
  • March 28, 2012
    pCODR Update 15
    (Invitation to Informational Webinar – Patient Advocacy Groups)
  • December 22, 2011
    pCODR Update 14
    (Invitation to Informational Webinar – Pharmaceutical Industry)
  • October 17, 2011
    pCODR Update 13
    (Invitation to Informational Webinar – Pharmaceutical Industry)
  • September 15, 2011
    pCODR Update 12
    (Invitation to Informational Webinar – Patient Advocacy Groups)
  • August 23, 2011
    pCODR Update 11
    (Invitation to Information Session - Pharmaceutical Industry)
  • August 9, 2011
    pCODR Update 10
    (Invitation to Information Session - Patient Advocacy Groups)
  • July 13, 2011
    pCODR Update 9
    (pCODR News Release)
  • July 7, 2011
    pCODR Update 8B
    (pCODR Update – Pharmaceutical Industry)
  • July 7, 2011
    pCODR Update 8A
    (pCODR Update – Patient Advocacy Groups)
  • June 6, 2011
    pCODR Update 7B
    (pCODR Update – Pharmaceutical Industry)
  • June 6, 2011
    pCODR Update 7A
    (pCODR Update – Patient Advocacy Groups)
  • April 12, 2011
    pCODR Update 6
    (pCODR Update - Portal Launch)
  • March 14, 2011
    pERC Chair Announcement
    (Selection of pCODR Expert Review Committee Chair)
  • February 4, 2011
    pCODR Update 5B
    (pCODR Update - Pharmaceutical Industry)
  • February 4, 2011
    pCODR Update 5A
    (pCODR Update - Patient Advocacy Groups)
  • January 11, 2011
    pCODR Update 4B
    (pCODR Steering Committee Direction on Feedback Received - Pharmaceutical Industry)
  • January 11, 2011
    pCODR Update 4A
    (pCODR Steering Committee Direction on Feedback Received - Patient Groups)
  • December 23, 2010
    pCODR Call for Patient Members
    (Advertisement to nominate/apply for pERC patient members)
  • December 21, 2010
    pCODR Update 3B
    (Summary of Feedback from Information Session - Pharmaceutical Industry)
  • December 21, 2010
    pCODR Update 3A
    (Summary of Feedback from Information Session - Patient Groups)
  • November 1, 2010
    pCODR Update 2B
    (Invitation to Information Session - Pharmaceutical Industry)
  • November 1, 2010
    pCODR Update 2A
    (Invitation to Information Session - Patient Groups)
  • October 18, 2010
    pCODR Update 1
    (External Stakeholder Communication)